Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai
Clinical trial NCT04524390 · COMPLETED
Trial details
- NCT number
- NCT04524390
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-08
- Primary completion
- 2023-11-07
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.